Stagezero Life Sciences Stock Fundamentals
| SZLS Stock | CAD 0.04 0.00 0.00% |
StageZero Life Sciences fundamentals help investors to digest information that contributes to StageZero Life's financial success or failures. It also enables traders to predict the movement of StageZero Stock. The fundamental analysis module provides a way to measure StageZero Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to StageZero Life stock.
At this time, StageZero Life's Other Operating Expenses is very stable compared to the past year. As of the 1st of December 2024, Income Tax Expense is likely to grow to about 4 M, while Interest Expense is likely to drop about 324.1 K. StageZero | Select Account or Indicator |
StageZero Life Sciences Company Return On Equity Analysis
StageZero Life's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current StageZero Life Return On Equity | -1.69 |
Most of StageZero Life's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, StageZero Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
StageZero Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for StageZero Life is extremely important. It helps to project a fair market value of StageZero Stock properly, considering its historical fundamentals such as Return On Equity. Since StageZero Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of StageZero Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of StageZero Life's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
StageZero Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, StageZero Life Sciences has a Return On Equity of -1.6885. This is 92.96% lower than that of the Biotechnology sector and 74.72% lower than that of the Health Care industry. The return on equity for all Canada stocks is notably higher than that of the company.
StageZero Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining StageZero Life's current stock value. Our valuation model uses many indicators to compare StageZero Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across StageZero Life competition to find correlations between indicators driving StageZero Life's intrinsic value. More Info.StageZero Life Sciences is rated second in return on equity category among its peers. It is rated fifth in return on asset category among its peers . At this time, StageZero Life's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value StageZero Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for StageZero Life's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.StageZero Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses StageZero Life's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of StageZero Life could also be used in its relative valuation, which is a method of valuing StageZero Life by comparing valuation metrics of similar companies.StageZero Life is currently under evaluation in return on equity category among its peers.
StageZero Life Current Valuation Drivers
We derive many important indicators used in calculating different scores of StageZero Life from analyzing StageZero Life's financial statements. These drivers represent accounts that assess StageZero Life's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of StageZero Life's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 756.8K | 26.2M | 16.3M | 4.4M | 4.0M | 3.0M | |
| Enterprise Value | 3.1M | 23.2M | 15.9M | 6.2M | 5.6M | 5.8M |
StageZero Fundamentals
| Return On Equity | -1.69 | ||||
| Return On Asset | -0.64 | ||||
| Operating Margin | (0.57) % | ||||
| Current Valuation | 6.71 M | ||||
| Shares Outstanding | 123.55 M | ||||
| Shares Owned By Insiders | 19.99 % | ||||
| Number Of Shares Shorted | 39.71 K | ||||
| Price To Book | 5.94 X | ||||
| Price To Sales | 1.70 X | ||||
| Revenue | 2.88 M | ||||
| Gross Profit | 1.18 M | ||||
| EBITDA | (4.46 M) | ||||
| Net Income | (12.53 M) | ||||
| Cash And Equivalents | 754.87 K | ||||
| Total Debt | 1.8 M | ||||
| Current Ratio | 0.18 X | ||||
| Book Value Per Share | (0.08) X | ||||
| Cash Flow From Operations | (809.15 K) | ||||
| Short Ratio | 0.50 X | ||||
| Earnings Per Share | (0.16) X | ||||
| Target Price | 1.25 | ||||
| Number Of Employees | 40 | ||||
| Beta | 0.074 | ||||
| Market Capitalization | 4.94 M | ||||
| Total Asset | 700.65 K | ||||
| Retained Earnings | (123.04 M) | ||||
| Working Capital | (6.76 M) | ||||
| Net Asset | 700.65 K |
About StageZero Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze StageZero Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of StageZero Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of StageZero Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 61.9 K | 58.8 K | |
| Total Revenue | 2.9 M | 1.7 M | |
| Cost Of Revenue | 2.9 M | 2.3 M | |
| Stock Based Compensation To Revenue | 0.07 | 0.07 | |
| Sales General And Administrative To Revenue | 1.40 | 1.33 | |
| Research And Ddevelopement To Revenue | 0.11 | 0.10 | |
| Revenue Per Share | 0.04 | 0.04 | |
| Ebit Per Revenue | (1.84) | (1.93) |
Pair Trading with StageZero Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if StageZero Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in StageZero Life will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to StageZero Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace StageZero Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back StageZero Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling StageZero Life Sciences to buy it.
The correlation of StageZero Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as StageZero Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if StageZero Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for StageZero Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in StageZero Stock
StageZero Life financial ratios help investors to determine whether StageZero Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in StageZero with respect to the benefits of owning StageZero Life security.